US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ALLURION TECHNOLOGIES

2.23

+0.04422.02%

Volume:27.74K

Turnover:61.38K

Market Cap:16.62M

PE:-0.31

High:2.24

Open:2.24

Low:2.18

Close:2.18

52wk High:22.25

52wk Low:1.98

Shares:7.46M

Float Shares:3.68M

Volume Ratio:0.61

T/O Rate:0.75%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-7.1080

EPS(LYR):-11.6360

ROE:--

ROA:-64.74%

PB:-0.26

PE(LYR):-0.19

Loading ...

Overview Company News Filings

Allurion Technologies Holdings Inc. Files Amendment to 10-Q Annual Report

Allurion Technologies Announces Restatement of Financial Statements Due to Accounting Errors

U.S. RESEARCH ROUNDUP-Air Products, Biogen and JLL

Allurion Technologies Enters Strategic Partnership for Development of GLP-1 Drug-Eluting Balloon and Expanded Distribution Capabilities

BRIEF-Allurion Technologies Q2 Revenue USD 3.379 Million

Allurion Reports Second Quarter 2025 Financial Results and Provides Business Update

THOMSON REUTERS

Allurion Technologies Inc: Re-Evaluating Guidance for 2025

THOMSON REUTERS

Allurion Technologies Q2 Operating Expenses USD 9.449 Million

THOMSON REUTERS

Allurion Technologies Inc expected to post a loss of 78 cents a share - Earnings Preview

Allurion Technologies Inc On August 5, Co Announced Strategic Restructuring Plan Which Includes Reduction In Workforce By 65% - SEC Filing

Allurion Technologies Inc - Expects $1.5 Mln Severance Charges Under Restructuring Plan - SEC Filing

THOMSON REUTERS

Allurion Technologies Reports Q2 2025 Revenue of $3 Million and Operating Loss of $7 Million, Improvement from Q2 2024 Loss of $9.3 Million

BRIEF-Allurion Shifts Strategy Toward Low-Dose GLP-1 Combos, Muscle Health and US Entry

Allurion Technologies Reports Q2 2025 Revenue of $3M and Reduced Operating Loss of $7M, Down from $9.3M in Q2 2024

Allurion Announces New Strategic Direction With Increasing Focus on Low-Dose Glp-1 Combination Therapy, Muscle Mass Maintenance, and US Market Entry

THOMSON REUTERS

Allurion Technologies Unveils New Studies Showing Long-Term Weight Loss Success with Allurion Program

Allurion Technologies announces distribution partnership with Minogue

Allurion Technologies Partners with Minogue Medical for Metabolically Healthy Weight Loss in Canada

Roth MKM Reaffirms Their Buy Rating on Allurion Technologies (ALUR)

Allurion Technologies submits PMA to FDA, announces additional AUDACITY data

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALUR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALUR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALUR\",,,,,undefined,":{"symbol":"ALUR","market":"US","secType":"STK","nameCN":"ALLURION TECHNOLOGIES","latestPrice":2.2282,"timestamp":1756313254449,"preClose":2.184,"halted":0,"volume":27740,"delay":0,"floatShares":3680196,"shares":7457758,"eps":-7.108048,"marketStatus":"Trading","change":0.0442,"latestTime":"08-27 12:48:58 EDT","open":2.24,"high":2.24,"low":2.1801,"amount":61384.434034000005,"amplitude":0.027427,"askPrice":2.26,"askSize":36,"bidPrice":2.18,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-7.108048,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1756324800000},"marketStatusCode":2,"adr":0,"exchange":"NYSE","adjPreClose":2.184,"preHourTrading":{"tag":"盘前","latestPrice":2.26,"preClose":2.184,"latestTime":"06:26 EDT","volume":1,"amount":2.26,"timestamp":1756290371820},"postHourTrading":{"tag":"盘后","latestPrice":2.3,"preClose":2.184,"latestTime":"18:13 EDT","volume":2404,"amount":5527.4264,"timestamp":1756246402885},"volumeRatio":0.607124,"impliedVol":0.5858,"impliedVolPercentile":0.2921},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALUR\",,,,,undefined,":{"symbol":"ALUR","floatShares":3680196,"roa":"-64.74%","roe":"--","lyrEps":-11.635999,"volumeRatio":0.607124,"shares":7457758,"dividePrice":0,"high":2.24,"amplitude":0.027427,"preClose":2.184,"low":2.1801,"week52Low":1.98,"pbRate":"-0.26","psRate":"0.83","week52High":22.245,"institutionHeld":0,"latestPrice":2.2282,"committee":0.470588,"eps":-7.108048,"divideRate":0,"volume":27740,"delay":0,"ttmEps":-7.108048,"open":2.24,"prevYearClose":10.75,"prevWeekClose":2.24,"prevMonthClose":2.78,"prevQuarterClose":2.43,"fiveDayClose":2.13,"twentyDayClose":2.73,"sixtyDayClose":2.72},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALUR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-13","symbol":"ALUR","fiscalQuarterEnding":"2025/06","expectedEps":-0.65,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":0.25},{"market":"US","date":"2025-05-14","symbol":"ALUR","fiscalQuarterEnding":"2025/03","expectedEps":-1.53,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"pre","actualEps":0.43},{"market":"US","date":"2025-03-26","symbol":"ALUR","fiscalQuarterEnding":"2024/12","expectedEps":5,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742961600000,"reportTimeType":"pre","actualEps":7},{"market":"US","date":"2025-01-14","symbol":"ALUR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1736830800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-01-03","symbol":"ALUR","defaultRemindTime":1735914600000,"type":"split","dateTimestamp":1735880400000,"forFactor":25,"toFactor":1,"ratio":25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALUR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALUR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1731643200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALUR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALUR","date":"2025-08-26","current":-0.544895,"percent":0.936508,"low":-4.394257,"twenty":-2.097573,"median":-1.16926,"eighty":-0.807254,"high":-0.310901,"avg":-1.437039,"sd":0.817597,"marketCap":16705377},"quantilePoints":[{"date":"2023-08-18","current":-2.037917,"twenty":-3.277082,"median":-2.839759,"eighty":-2.134151,"marketCap":133925760},{"date":"2023-08-25","current":-2.236047,"twenty":-2.898447,"median":-2.214819,"eighty":-2.105847,"marketCap":146946320},{"date":"2023-09-01","current":-2.816287,"twenty":-2.825676,"median":-2.250199,"eighty":-2.144058,"marketCap":185077960},{"date":"2023-09-08","current":-3.382375,"twenty":-3.27846,"median":-2.504939,"eighty":-2.172362,"marketCap":222279560},{"date":"2023-09-15","current":-3.86355,"twenty":-3.420586,"median":-2.839759,"eighty":-2.196421,"marketCap":253900920},{"date":"2023-09-22","current":-3.849398,"twenty":-3.840907,"median":-3.25425,"eighty":-2.214819,"marketCap":252970880},{"date":"2023-09-29","current":-2.986114,"twenty":-3.811187,"median":-3.133201,"eighty":-2.247369,"marketCap":196238440},{"date":"2023-10-06","current":-3.346995,"twenty":-3.729104,"median":-3.240853,"eighty":-2.275674,"marketCap":219954460},{"date":"2023-10-13","current":-3.12056,"twenty":-3.596073,"median":-3.233777,"eighty":-2.462482,"marketCap":205073820},{"date":"2023-10-20","current":-3.127636,"twenty":-3.515406,"median":-3.279772,"eighty":-2.734205,"marketCap":205538840},{"date":"2023-10-27","current":-3.118177,"twenty":-3.506915,"median":-3.247929,"eighty":-2.751188,"marketCap":204917216},{"date":"2023-11-03","current":-3.160601,"twenty":-3.44606,"median":-3.226701,"eighty":-2.804965,"marketCap":207705205},{"date":"2023-11-10","current":-3.026258,"twenty":-3.414926,"median":-3.168884,"eighty":-2.835065,"marketCap":198876572},{"date":"2023-11-17","current":-2.73411,"twenty":-3.405019,"median":-3.127636,"eighty":-2.780397,"marketCap":201708999},{"date":"2023-11-24","current":-2.498541,"twenty":-3.403604,"median":-3.118177,"eighty":-2.727355,"marketCap":184329841},{"date":"2023-12-01","current":-2.401948,"twenty":-3.390867,"median":-3.062787,"eighty":-2.517859,"marketCap":177203687},{"date":"2023-12-08","current":-2.131487,"twenty":-3.378129,"median":-3.042723,"eighty":-2.431569,"marketCap":157250457},{"date":"2023-12-15","current":-2.211861,"twenty":-3.366808,"median":-3.022722,"eighty":-2.28228,"marketCap":163180039},{"date":"2023-12-22","current":-2.284298,"twenty":-3.361147,"median":-2.969692,"eighty":-2.258787,"marketCap":168524069},{"date":"2023-12-29","current":-2.50951,"twenty":-3.358317,"median":-2.963751,"eighty":-2.253222,"marketCap":185139119},{"date":"2024-01-05","current":-2.174909,"twenty":-3.349825,"median":-2.941409,"eighty":-2.243761,"marketCap":160453903},{"date":"2024-01-12","current":-2.168474,"twenty":-3.341334,"median":-2.806389,"eighty":-2.214533,"marketCap":159979187},{"date":"2024-01-19","current":-2.039781,"twenty":-3.322936,"median":-2.772628,"eighty":-2.209949,"marketCap":150484873},{"date":"2024-01-26","current":-1.969,"twenty":-3.307368,"median":-2.73411,"eighty":-2.194213,"marketCap":145263001},{"date":"2024-02-02","current":-1.904654,"twenty":-3.300292,"median":-2.63612,"eighty":-2.172335,"marketCap":140515844},{"date":"2024-02-09","current":-1.904654,"twenty":-3.276234,"median":-2.50951,"eighty":-2.159537,"marketCap":140515844},{"date":"2024-02-16","current":-1.853177,"twenty":-3.245099,"median":-2.495321,"eighty":-2.128024,"marketCap":136718118},{"date":"2024-02-23","current":-1.769526,"twenty":-3.232789,"median":-2.427706,"eighty":-2.053281,"marketCap":130546814},{"date":"2024-03-01","current":-2.06552,"twenty":-3.229465,"median":-2.380817,"eighty":-2.023593,"marketCap":152383736},{"date":"2024-03-08","current":-1.737353,"twenty":-3.214402,"median":-2.288477,"eighty":-1.984444,"marketCap":128173236},{"date":"2024-03-15","current":-1.756657,"twenty":-3.18844,"median":-2.276159,"eighty":-1.962566,"marketCap":129597383},{"date":"2024-03-22","current":-1.183742,"twenty":-3.170541,"median":-2.265535,"eighty":-1.935541,"marketCap":95417853},{"date":"2024-03-28","current":-1.041238,"twenty":-3.155121,"median":-2.2545,"eighty":-1.923958,"marketCap":83931048},{"date":"2024-04-05","current":-1.828437,"twenty":-3.132088,"median":-2.24569,"eighty":-1.904654,"marketCap":147384785},{"date":"2024-04-12","current":-1.406946,"twenty":-3.126221,"median":-2.216746,"eighty":-1.837734,"marketCap":113409721},{"date":"2024-04-19","current":-1.21222,"twenty":-3.120083,"median":-2.207082,"eighty":-1.808134,"marketCap":97713423},{"date":"2024-04-26","current":-1.099317,"twenty":-3.115349,"median":-2.19744,"eighty":-1.781109,"marketCap":88612663},{"date":"2024-05-03","current":-1.307296,"twenty":-3.098849,"median":-2.193591,"eighty":-1.739927,"marketCap":105377221},{"date":"2024-05-10","current":-1.2657,"twenty":-3.071976,"median":-2.171691,"eighty":-1.682015,"marketCap":102024309},{"date":"2024-05-17","current":-1.557002,"twenty":-3.046521,"median":-2.16204,"eighty":-1.465452,"marketCap":89091650},{"date":"2024-05-24","current":-1.290455,"twenty":-3.042723,"median":-2.15369,"eighty":-1.416683,"marketCap":73839846},{"date":"2024-05-31","current":-1.265316,"twenty":-3.042723,"median":-2.134707,"eighty":-1.40101,"marketCap":72401404},{"date":"2024-06-07","current":-1.055827,"twenty":-3.033328,"median":-2.091259,"eighty":-1.366719,"marketCap":60414417},{"date":"2024-06-14","current":-1.030688,"twenty":-3.026258,"median":-2.069526,"eighty":-1.340733,"marketCap":58975978},{"date":"2024-06-21","current":-1.910544,"twenty":-3.020601,"median":-2.05265,"eighty":-1.33065,"marketCap":109321326},{"date":"2024-06-28","current":-1.087116,"twenty":-2.992729,"median":-2.037917,"eighty":-1.30728,"marketCap":62204799},{"date":"2024-07-05","current":-1.303159,"twenty":-2.976261,"median":-1.988304,"eighty":-1.305592,"marketCap":74566772},{"date":"2024-07-12","current":-1.190818,"twenty":-2.969692,"median":-1.978652,"eighty":-1.272831,"marketCap":68138602},{"date":"2024-07-19","current":-0.960518,"twenty":-2.962562,"median":-1.962566,"eighty":-1.263093,"marketCap":54960853},{"date":"2024-07-26","current":-0.965686,"twenty":-2.947969,"median":-1.954567,"eighty":-1.217188,"marketCap":55256549},{"date":"2024-08-02","current":-0.946925,"twenty":-2.880419,"median":-1.930393,"eighty":-1.194393,"marketCap":54183044},{"date":"2024-08-09","current":-0.864803,"twenty":-2.825676,"median":-1.923958,"eighty":-1.182114,"marketCap":49484052},{"date":"2024-08-16","current":-1.135987,"twenty":-2.80441,"median":-1.911089,"eighty":-1.17509,"marketCap":42470010},{"date":"2024-08-23","current":-1.174714,"twenty":-2.789942,"median":-1.904654,"eighty":-1.164761,"marketCap":43917851},{"date":"2024-08-30","current":-1.13461,"twenty":-2.770038,"median":-1.88535,"eighty":-1.161461,"marketCap":42418531},{"date":"2024-09-06","current":-1.024109,"twenty":-2.753105,"median":-1.833873,"eighty":-1.157202,"marketCap":38287357},{"date":"2024-09-13","current":-1.058705,"twenty":-2.73959,"median":-1.818285,"eighty":-1.141628,"marketCap":39580762},{"date":"2024-09-20","current":-1.072991,"twenty":-2.727355,"median":-1.808134,"eighty":-1.134754,"marketCap":40114854},{"date":"2024-09-27","current":-1.076778,"twenty":-2.696024,"median":-1.78883,"eighty":-1.119463,"marketCap":40256421},{"date":"2024-10-04","current":-1.213441,"twenty":-2.641741,"median":-1.766276,"eighty":-1.118155,"marketCap":45365692},{"date":"2024-10-11","current":-1.187967,"twenty":-2.577103,"median":-1.743788,"eighty":-1.119463,"marketCap":44413334},{"date":"2024-10-18","current":-1.213441,"twenty":-2.522247,"median":-1.70518,"eighty":-1.121663,"marketCap":45365692},{"date":"2024-10-25","current":-1.308278,"twenty":-2.505122,"median":-1.643334,"eighty":-1.123413,"marketCap":48911294},{"date":"2024-11-01","current":-1.221117,"twenty":-2.498541,"median":-1.566981,"eighty":-1.127892,"marketCap":45652687},{"date":"2024-11-08","current":-1.272964,"twenty":-2.495965,"median":-1.462114,"eighty":-1.134754,"marketCap":47591037},{"date":"2024-11-15","current":-1.092904,"twenty":-2.47407,"median":-1.422056,"eighty":-1.134754,"marketCap":27060299},{"date":"2024-11-22","current":-1.369794,"twenty":-2.431569,"median":-1.420438,"eighty":-1.135377,"marketCap":33916100},{"date":"2024-11-29","current":-1.210797,"twenty":-2.407099,"median":-1.416149,"eighty":-1.136751,"marketCap":29979340},{"date":"2024-12-06","current":-1.190086,"twenty":-2.397722,"median":-1.40101,"eighty":-1.136751,"marketCap":29466535},{"date":"2024-12-13","current":-1.101188,"twenty":-2.376028,"median":-1.386169,"eighty":-1.134682,"marketCap":27265420},{"date":"2024-12-20","current":-0.910721,"twenty":-2.344028,"median":-1.373062,"eighty":-1.121079,"marketCap":22549443},{"date":"2024-12-27","current":-1.137877,"twenty":-2.292656,"median":-1.366719,"eighty":-1.118775,"marketCap":28173844},{"date":"2025-01-03","current":-0.83221,"twenty":-2.28597,"median":-1.365391,"eighty":-1.115457,"marketCap":20605525},{"date":"2025-01-10","current":-0.39988,"twenty":-2.284298,"median":-1.351275,"eighty":-1.102518,"marketCap":9901019},{"date":"2025-01-17","current":-0.406323,"twenty":-2.279415,"median":-1.335283,"eighty":-1.099866,"marketCap":10060568},{"date":"2025-01-24","current":-1.205103,"twenty":-2.274267,"median":-1.324577,"eighty":-1.093536,"marketCap":29838340},{"date":"2025-01-31","current":-1.138286,"twenty":-2.269544,"median":-1.32222,"eighty":-1.092252,"marketCap":28183963},{"date":"2025-02-07","current":-1.16926,"twenty":-2.265771,"median":-1.307255,"eighty":-1.093536,"marketCap":28950873},{"date":"2025-02-14","current":-0.996968,"twenty":-2.262035,"median":-1.303159,"eighty":-1.087243,"marketCap":24684933},{"date":"2025-02-21","current":-0.854769,"twenty":-2.256935,"median":-1.290455,"eighty":-1.084351,"marketCap":21164084},{"date":"2025-02-28","current":-0.765681,"twenty":-2.24949,"median":-1.277613,"eighty":-1.076503,"marketCap":18958250},{"date":"2025-03-07","current":-0.585096,"twenty":-2.24569,"median":-1.274523,"eighty":-1.069805,"marketCap":14486965},{"date":"2025-03-14","current":-0.573233,"twenty":-2.243761,"median":-1.265508,"eighty":-1.056403,"marketCap":14193246},{"date":"2025-03-21","current":-0.862258,"twenty":-2.232496,"median":-1.265316,"eighty":-1.043361,"marketCap":21349505},{"date":"2025-03-28","current":-0.729821,"twenty":-2.217673,"median":-1.25845,"eighty":-1.031687,"marketCap":19083356},{"date":"2025-04-04","current":-0.6614,"twenty":-2.214533,"median":-1.257286,"eighty":-1.02112,"marketCap":17294292},{"date":"2025-04-11","current":-0.554208,"twenty":-2.210905,"median":-1.243778,"eighty":-1.007359,"marketCap":14491424},{"date":"2025-04-17","current":-0.533682,"twenty":-2.207082,"median":-1.237015,"eighty":-0.99717,"marketCap":13954704},{"date":"2025-04-25","current":-0.547366,"twenty":-2.207082,"median":-1.227662,"eighty":-0.988379,"marketCap":14312517},{"date":"2025-05-02","current":-0.531401,"twenty":-2.200667,"median":-1.222611,"eighty":-0.975674,"marketCap":13895069},{"date":"2025-05-09","current":-0.542804,"twenty":-2.194213,"median":-1.219637,"eighty":-0.972876,"marketCap":14193246},{"date":"2025-05-16","current":-0.776204,"twenty":-2.194213,"median":-1.214364,"eighty":-0.946925,"marketCap":18904450},{"date":"2025-05-23","current":-0.722335,"twenty":-2.193591,"median":-1.213441,"eighty":-0.910721,"marketCap":17592469},{"date":"2025-05-30","current":-0.805334,"twenty":-2.18167,"median":-1.213441,"eighty":-0.891125,"marketCap":19613903},{"date":"2025-06-06","current":-0.826768,"twenty":-2.176989,"median":-1.212056,"eighty":-0.87515,"marketCap":20135946},{"date":"2025-06-13","current":-0.783899,"twenty":-2.17524,"median":-1.210797,"eighty":-0.86076,"marketCap":19091860},{"date":"2025-06-20","current":-0.74103,"twenty":-2.171048,"median":-1.205103,"eighty":-0.846888,"marketCap":18047774},{"date":"2025-06-27","current":-0.765526,"twenty":-2.164614,"median":-1.199148,"eighty":-0.831705,"marketCap":18644395},{"date":"2025-07-03","current":-0.768588,"twenty":-2.16204,"median":-1.195798,"eighty":-0.829831,"marketCap":18718972},{"date":"2025-07-11","current":-0.91557,"twenty":-2.161393,"median":-1.194393,"eighty":-0.824931,"marketCap":22298696},{"date":"2025-07-18","current":-0.909445,"twenty":-2.159537,"median":-1.192657,"eighty":-0.827993,"marketCap":22149541},{"date":"2025-07-25","current":-0.897197,"twenty":-2.154594,"median":-1.190479,"eighty":-0.829831,"marketCap":21851230},{"date":"2025-08-01","current":-0.851265,"twenty":-2.144673,"median":-1.187795,"eighty":-0.829831,"marketCap":20732567},{"date":"2025-08-08","current":-0.845141,"twenty":-2.135351,"median":-1.182509,"eighty":-0.830277,"marketCap":20583412},{"date":"2025-08-15","current":-0.762464,"twenty":-2.128024,"median":-1.177149,"eighty":-0.824931,"marketCap":18569817},{"date":"2025-08-22","current":-0.48408,"twenty":-2.110202,"median":-1.171099,"eighty":-0.81411,"marketCap":14840938},{"date":"2025-08-26","current":-0.544895,"twenty":-2.097573,"median":-1.16926,"eighty":-0.807254,"marketCap":16705377}],"updateTime":1756291331335},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALUR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2560117599","title":"Allurion Technologies Holdings Inc. Files Amendment to 10-Q Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2560117599","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560117599?lang=en_us&edition=fundamental","pubTime":"2025-08-20 04:54","pubTimestamp":1755636850,"startTime":"0","endTime":"0","summary":"Allurion Technologies Holdings Inc. filed an amendment to the 10-Q annual report for the financial year ended March 31, 2025. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allurion Technologies Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 19, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250819:nNDL6PzB7Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1504","02018","BK4192","BK1500","BK1608","ALUR","SG9999006597.SGD","BK1607","BK1167","SG9999014674.SGD"],"gpt_icon":0},{"id":"2559725962","title":"Allurion Technologies Announces Restatement of Financial Statements Due to Accounting Errors","url":"https://stock-news.laohu8.com/highlight/detail?id=2559725962","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559725962?lang=en_us&edition=fundamental","pubTime":"2025-08-15 05:23","pubTimestamp":1755206585,"startTime":"0","endTime":"0","summary":"Allurion Technologies Holdings Inc. has announced that certain previously issued financial statements should no longer be relied upon due to identified accounting errors related to the fair value of its revenue interest financing agreement  and convertible senior secured notes. The company plans to restate financial statements for several periods, including annual periods ending December 31, 2023, and 2024, as well as quarterly reports from 2024 and early 2025. These errors, which affect non-cash elements of Other Comprehensive Income, Other Income, and Net Income, do not impact reported revenue, gross margin, operating expenses, or cash. The company has stated it will correct these misstatements through amendments to its annual and quarterly reports but does not plan to file amendments for prior quarters individually. The Audit Committee has advised that these financial statements and related reports should no longer be relied upon.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nNDL2FX8PH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4192","02018","BK1608","ALUR","SG9999006597.SGD","BK1607","BK1504","BK1167","BK1500","SG9999014674.SGD"],"gpt_icon":0},{"id":"2559493783","title":"U.S. RESEARCH ROUNDUP-Air Products, Biogen and JLL","url":"https://stock-news.laohu8.com/highlight/detail?id=2559493783","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559493783?lang=en_us&edition=fundamental","pubTime":"2025-08-14 15:12","pubTimestamp":1755155538,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Air Products, Biogen and JLLAug 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Air Products, B","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nL4N3U60DR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WAL","LU0203347892.USD","IBTA","BK4525","BK4534","APD","LU2506952097.USD","LU0823417653.USD","LU1244550577.SGD","LU2236285917.USD","LU1894683264.USD","FHI","SG9999015952.SGD","LU1244550494.USD","BK4079","TKO","BK4203","LU1923622291.USD","JLL","ALUR","INSM","KLC","KOD","LU1046421795.USD","SPHR","BK4184","SG9999001440.SGD","CSCO","OHI","EQH","LU2237443895.HKD","BK4550","SARO","WAB","BIIB","IE00B3PB1722.GBP","MRSN","LU0234570918.USD","IE000M9KFDE8.USD","SG9999001424.SGD","LU1066053197.SGD","IE00BKVL7J92.USD","BK4563","BK4211","LU1093756325.SGD","IE00B42XCP33.USD","LU0320765992.SGD","PNNT","BK4187"],"gpt_icon":0},{"id":"2559604484","title":"Allurion Technologies Enters Strategic Partnership for Development of GLP-1 Drug-Eluting Balloon and Expanded Distribution Capabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2559604484","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559604484?lang=en_us&edition=fundamental","pubTime":"2025-08-13 20:16","pubTimestamp":1755087362,"startTime":"0","endTime":"0","summary":"Allurion Technologies Enters Strategic Partnership for Development of GLP-1 Drug-Eluting Balloon and Expanded Distribution Capabilities. Allurion Technologies Holdings Inc. has announced a significant collaboration with a strategic partner to enhance its manufacturing and distribution capabilities as well as its R&D pipeline. This partnership includes the potential joint development of a novel GLP-1 drug-eluting balloon, marking a pivotal step in Allurion's new strategic direction. The collaboration aims to advance the company's focus on low-dose GLP-1 combination therapy and muscle mass maintenance, further strengthening Allurion's entry into the U.S. market. This initiative is expected to establish a new standard of care in obesity treatment, enabling patients to achieve meaningful weight loss while preserving muscle mass.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely informat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDL2h8LMF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4192","BK1167","02018","SG9999014674.SGD","BK1500","ALUR","BK1504","BK1608","BK1607","SG9999006597.SGD"],"gpt_icon":0},{"id":"2559604571","title":"BRIEF-Allurion Technologies Q2 Revenue USD 3.379 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2559604571","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559604571?lang=en_us&edition=fundamental","pubTime":"2025-08-13 20:00","pubTimestamp":1755086448,"startTime":"0","endTime":"0","summary":"BRIEF-Allurion Technologies Q2 Revenue USD 3.379 Million\n\n\nAug 13 (Reuters) - Allurion Technologies Q2 operating expenses USD 9.449 million.\n\nQ2 gross profit USD 2.497 million\nQ2 income from operations USD -6.952 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nPLXA8C910:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALUR"],"gpt_icon":0},{"id":"2559331604","title":"Allurion Reports Second Quarter 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2559331604","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559331604?lang=en_us&edition=fundamental","pubTime":"2025-08-13 20:00","pubTimestamp":1755086403,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nTUA5MWTFB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2559860499","title":"Allurion Technologies Inc: Re-Evaluating Guidance for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2559860499","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559860499?lang=en_us&edition=fundamental","pubTime":"2025-08-13 20:00","pubTimestamp":1755086403,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nPLXA8C910:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2559060439","title":"Allurion Technologies Q2 Operating Expenses USD 9.449 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2559060439","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559060439?lang=en_us&edition=fundamental","pubTime":"2025-08-13 20:00","pubTimestamp":1755086403,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nPLXA8C910:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4192","ALUR"],"gpt_icon":0},{"id":"2557575170","title":"Allurion Technologies Inc  expected to post a loss of 78 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2557575170","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557575170?lang=en_us&edition=fundamental","pubTime":"2025-08-08 23:55","pubTimestamp":1754668519,"startTime":"0","endTime":"0","summary":"Allurion Technologies Inc  expected to post a loss of78cents a share - Earnings Preview Allurion Technologies Inc ALUR.N, ALUR.K is expected to  show a fall in quarterly revenue when it reports  resul","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL8N3U02V9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALUR"],"gpt_icon":0},{"id":"2557565559","title":"Allurion Technologies Inc On August 5, Co Announced Strategic Restructuring Plan Which Includes Reduction In Workforce By 65% - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2557565559","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557565559?lang=en_us&edition=fundamental","pubTime":"2025-08-07 20:33","pubTimestamp":1754570009,"startTime":"0","endTime":"0","summary":"Aug 7 (Reuters) - Allurion Technologies Inc ::*ALLURION TECHNOLOGIES INC:  ON AUGUST 5, CO ANNOUNCED STRATEGIC RESTRUCTURING PLAN WHICH INCLUDES REDUCTION IN WORKFORCE BY 65%  - SEC FILING*ALLURION TE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nRSD9m3sbX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Allurion Technologies Inc On August 5, Co Announced Strategic Restructuring Plan Which Includes Reduction In Workforce By 65% - SEC Filing","news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALUR","BK4192"],"gpt_icon":1},{"id":"2557755676","title":"Allurion Technologies Inc - Expects $1.5 Mln Severance Charges Under Restructuring Plan - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2557755676","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557755676?lang=en_us&edition=fundamental","pubTime":"2025-08-07 18:18","pubTimestamp":1754561910,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nFWN3TZ118:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2557250556","title":"Allurion Technologies Reports Q2 2025 Revenue of $3 Million and Operating Loss of $7 Million, Improvement from Q2 2024 Loss of $9.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2557250556","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557250556?lang=en_us&edition=fundamental","pubTime":"2025-08-07 18:07","pubTimestamp":1754561230,"startTime":"0","endTime":"0","summary":"Allurion Technologies Reports Q2 2025 Revenue of $3 Million and Operating Loss of $7 Million, Improvement from Q2 2024 Loss of $9.3 Million. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allurion Technologies Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 07, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nNDLVBks8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02018","ALUR"],"gpt_icon":0},{"id":"2557394058","title":"BRIEF-Allurion Shifts Strategy Toward Low-Dose GLP-1 Combos, Muscle Health and US Entry","url":"https://stock-news.laohu8.com/highlight/detail?id=2557394058","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557394058?lang=en_us&edition=fundamental","pubTime":"2025-08-05 21:17","pubTimestamp":1754399849,"startTime":"0","endTime":"0","summary":"BRIEF-Allurion Shifts Strategy Toward Low-Dose GLP-1 Combos, Muscle Health and US EntryAug 5 (Reuters) - Allurion Technologies Inc ALUR.N:ALLURION ANNOUNCES NEW STRATEGIC DIRECTION WITH INCREASING FOC","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nTUABXT6KV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2557399691","title":"Allurion Technologies Reports Q2 2025 Revenue of $3M and Reduced Operating Loss of $7M, Down from $9.3M in Q2 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2557399691","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557399691?lang=en_us&edition=fundamental","pubTime":"2025-08-05 20:01","pubTimestamp":1754395291,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allurion Technologies Holdings Inc. published the original content used to generate this news brief via Business Wire  on August 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nNDL2KLkqC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALUR","02018"],"gpt_icon":0},{"id":"2557967383","title":"Allurion Announces New Strategic Direction With Increasing Focus on Low-Dose Glp-1 Combination Therapy, Muscle Mass Maintenance, and US Market Entry","url":"https://stock-news.laohu8.com/highlight/detail?id=2557967383","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557967383?lang=en_us&edition=fundamental","pubTime":"2025-08-05 20:00","pubTimestamp":1754395205,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nTUABXT6KV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4192","ALUR"],"gpt_icon":0},{"id":"2553531162","title":"Allurion Technologies Unveils New Studies Showing Long-Term Weight Loss Success with Allurion Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2553531162","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553531162?lang=en_us&edition=fundamental","pubTime":"2025-07-22 20:00","pubTimestamp":1753185643,"startTime":"0","endTime":"0","summary":"Allurion Technologies Holdings Inc. has announced the publication of new long-term weight loss results from studies involving the Allurion Program. The findings, presented in publications, indicate that in a study of 522 patients, participants achieved an average weight loss of approximately 32 pounds at the time of balloon passage, with 95% of this weight loss maintained one year later. In a separate study involving 497 patients, the average weight loss was 14.3% of total body weight, with 86% of patients maintaining this weight loss one year after the initial treatment. These results highlight the potential of the Allurion Program in achieving and maintaining significant weight loss.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. All","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250722:nNDL3trMtB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014674.SGD","BK4192","BK1504","BK1607","BK1608","SG9999006597.SGD","BK1500","BK1167","ALUR","02018"],"gpt_icon":0},{"id":"2550663658","title":"Allurion Technologies announces distribution partnership with Minogue","url":"https://stock-news.laohu8.com/highlight/detail?id=2550663658","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550663658?lang=en_us&edition=fundamental","pubTime":"2025-07-10 04:10","pubTimestamp":1752091853,"startTime":"0","endTime":"0","summary":"Allurion Technologies (ALUR) “announced a strategic distribution partnership with Minogue Medical Inc., a leading Canadian medical device company s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/allurion-technologies-announces-distribution-partnership-with-minogue-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/allurion-technologies-announces-distribution-partnership-with-minogue-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2550668716","title":"Allurion Technologies Partners with Minogue Medical for Metabolically Healthy Weight Loss in Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2550668716","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550668716?lang=en_us&edition=fundamental","pubTime":"2025-07-10 04:05","pubTimestamp":1752091531,"startTime":"0","endTime":"0","summary":"Allurion Technologies, Inc.  has announced a strategic distribution partnership with Minogue Medical Inc., a leading Canadian medical device company specializing in bariatric and obesity care. This collaboration aims to introduce a new standard of care in obesity management, focusing on metabolically healthy weight loss. By leveraging Minogue Medical's extensive experience and national network of healthcare professionals in Canada, Allurion plans to enhance access to its innovative weight loss solutions. The partnership will also promote the integration of the Allurion Program with GLP-1 therapy to improve both short and long-term weight management outcomes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allurion Technologies Holdings ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nNDL5B3tjl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1167","BK1607","BK1500","02018","SG9999006597.SGD","BK1504","BK4192","ALUR","SG9999014674.SGD","BK1608"],"gpt_icon":0},{"id":"2549568331","title":"Roth MKM Reaffirms Their Buy Rating on Allurion Technologies (ALUR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2549568331","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549568331?lang=en_us&edition=fundamental","pubTime":"2025-07-08 04:55","pubTimestamp":1751921714,"startTime":"0","endTime":"0","summary":"In a report released today, Jason Wittes from Roth MKM reiterated a Buy rating on Allurion Technologies, with a price target of $16.00. The company...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-reaffirms-their-buy-rating-on-allurion-technologies-alur-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-reaffirms-their-buy-rating-on-allurion-technologies-alur-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALUR"],"gpt_icon":0},{"id":"2549051534","title":"Allurion Technologies submits PMA to FDA, announces additional AUDACITY data","url":"https://stock-news.laohu8.com/highlight/detail?id=2549051534","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549051534?lang=en_us&edition=fundamental","pubTime":"2025-07-07 20:10","pubTimestamp":1751890231,"startTime":"0","endTime":"0","summary":"Allurion Technologies (ALUR) announced submission of the fourth and final module of the pre-market approval application to the FDA and additional, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/allurion-technologies-submits-pma-to-fda-announces-additional-audacity-data-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/allurion-technologies-submits-pma-to-fda-announces-additional-audacity-data-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4192","ALUR"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":59,"code":"91000000","status":"200"}]}}